Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × pegilodecakin × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2 Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Fluorouracil 256 Oxaliplatin 243 Leucovorin 200 Gemcitabine 198 Capecitabine 194 Bevacizumab 183 Irinotecan 152 pembrolizumab 116 Cisplatin 113 Radiotherapy 99 Cetuximab 98 Sorafenib 68 Nivolumab 67 130-nm albumin-bound paclitaxel 57 Docetaxel 56 Erlotinib Hydrochloride 54 Albumin-Bound Paclitaxel 52 Paclitaxel 51 Panitumumab 48 Folfox protocol 42 regorafenib 39 Radiosurgery 38 Sunitinib 35 Radiation 35 Ramucirumab 31 durvalumab 29 Surgical Procedures, Operative 29 Magnetic Resonance Spectroscopy 27 Cyclophosphamide 27 Carboplatin 27

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02923921 2020-10-19

Sequoia

Eli Lilly and Company

Phase 3 Completed

567 enrolled 17 charts

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡